Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Assets: 2009-2022

Historic Assets for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Sep 2022 value amounting to $145.8 million.

  • Avadel Pharmaceuticals' Assets fell 44.81% to $145.8 million in Q3 2022 from the same period last year, while for Sep 2022 it was $145.8 million, marking a year-over-year decrease of 44.81%. This contributed to the annual value of $247.3 million for FY2021, which is 20.66% down from last year.
  • According to the latest figures from Q3 2022, Avadel Pharmaceuticals' Assets is $145.8 million, which was down 7.71% from $157.9 million recorded in Q2 2022.
  • Over the past 5 years, Avadel Pharmaceuticals' Assets peaked at $351.9 million during Q1 2018, and registered a low of $145.8 million during Q3 2022.
  • Its 3-year average for Assets is $254.6 million, with a median of $264.1 million in 2021.
  • In the last 5 years, Avadel Pharmaceuticals' Assets crashed by 50.66% in 2019 and then skyrocketed by 110.17% in 2020.
  • Quarterly analysis of 5 years shows Avadel Pharmaceuticals' Assets stood at $190.3 million in 2018, then fell by 20.42% to $151.4 million in 2019, then surged by 105.79% to $311.6 million in 2020, then dropped by 20.66% to $247.3 million in 2021, then crashed by 44.81% to $145.8 million in 2022.
  • Its Assets stands at $145.8 million for Q3 2022, versus $157.9 million for Q2 2022 and $221.1 million for Q1 2022.